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Why Do the Study?
To Err is Human:  Building a Safer 
Healthcare System*
Report issued by the Institute of Medicine in 
late 1999 
Highlighted the alarming frequency of ME
*Source:  http:// www.iom.edu
Implications of To Err
Outlined a series of broad policy 
recommendations to improve patient 
safety & reduce medical error which 
includes ME
Call to action for state and federal 
agencies regarding ME
KY Board of Pharmacy Response
Concerned about KY Pharmacists’
contributions to the error statistics
Appointed a Statewide ME Task Force
Analyze the current status of ME in KY
Evaluate the KY Board’s response to ME
Task Force Considerations
Historically, the KY Board
Imposed actions on individual pharmacist in the 
event of ME 
Provided no clear guidance on or consideration 
of ME Prevention (QA) programs
Expert Counsel
System failures responsible for most ME
QA programs within organizations key
Task Force Consensus
Important to first examine systems in 
which pharmacists are functioning
Report to BOP in terms of guidance in 
regards to ME and patient safety
Study Aims
Determine pharmacists perceptions on:
Factors most associated with ME
Presence of ME tracking systems
Most common types of ME
Determine if there is a difference between 
perceptions of Hospital vs. Community 
pharmacists
HO: ų1 =  ų2
Study Results
3511 surveys mailed
34.1% response rate
(n=1198)Academia
1% Chain
43%
Independent
26%
LTC
4%
Industry 
<1%
Hospital
18%
Other
8%
87.4% (n=918) were 
Hospital or Community 
pharmacists
Female
43%Male
57%
What are the Most Common 
Causes/Types of Medication Errors?
Perceptions from both groups indicate:
Poor Handwriting
Prescription Volume
Pharmacist Overwork
Pharmacist Fatigue
Noise, Distractions or Interruptions
Most Common Types of ME
Technical in nature
Incorrect medicine, Incorrect Strength, Wrong 
Patient
Factors Associated w/ME: Practically 
Significant?
Factor Assessed
Insurance 
Processing
Presence of ME Tracking Systems
KY law requires pharmacist-in-charge to 
implement and maintain QA Programs 
(ME Tracking/Reporting Systems)
Over 90% of pharmacists in both groups 
felt that the risk of ME is increasing
Are ME Tracking Systems in 
Place?
Only 80% of community pharmacists 
perceive they have such systems in place
95% of hospital pharmacists perceive they 
do as well
P-value = <0.001
Implications of these Findings
Three most common types of ME are 
technical in nature as opposed to 
knowledge deficiencies
Supports the expert panels’ position that 
most ME are due to system failures
Implications of Findings continued
The goal should be and the mandate is 
that 100% of pharmacies at least have a 
ME tracking system in place
Learning from ME begins with reporting them
In this regard, the findings suggest: 
KY BOP does not provide enough guidance 
for meaningful QA in pharmacies
Hesitancy: current mandate does not protect 
ME data from discovery in court of law
Recommendations
I. Re-evaluate 201 KAR 2:225 (QA in 
pharmacies)
a) Include peer review protection
b) Provide sufficient detail for meaningful programs
II. Re-examine Board procedures that currently 
classify ME as unprofessional conduct
a) Consider presence of QA when acting on a ME 
case
b) Actively educate pharmacists on importance of QA 
via continuing education programs, periodic 
newsletter and inspections
Questions?
